COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 472: Articles 4711-4720  | Next

Risk factors for SARS-CoV-2 infection: A test-negative case-control study with additional population controls
Sarjomaa, M., Zhang, C., Tveten, Y., Kersten, H., Reiso, H., Eikeland, R., Kongerud, J., Berg, K. K., Thilesen, C., Nordbo, S. A., Aaberge, I., Vandenbroucke, J., Pearce, N., Fell, A. K.
10.1101/2023.03.15.23287300 — Posted: 2023-03-19
The effects of COVID-19 on cognitive performance in a community-based cohort: A COVID Symptom Study Biobank observational study
Cheetham, N. J., Penfold, R., Giunchiglia, V., Bowyer, V., Sudre, C. H., Canas, L. S., Deng, J., Murray, B., Kerfoot, E., Antonelli, M., Rjoob, K., Molteni, E., Osterdahl, M. F., Harvey, N. R., Trender, W. R., Malim, M. H., Doores, K. J., Hellyer, P. J., Modat, M., Hammers, A., Ourselin, S., Duncan, E. L., Hampshire, A., Steves, C. J.
10.1101/2023.03.14.23287211 — Posted: 2023-03-19
Effect of Andrographis paniculata treatment for patients with early-stage COVID-19 on the prevention of pneumonia: A retrospective cohort study
Benjaponpitak, A., Sawaengtham, T., Thaneerat, T., Wanaratna, K., Chotsiri, P., Rungsawang, C., Bhubhanilc, S., Charoensuk, S., Benjaponpitak, S., Lapmanee, S., Sirinavin, S.
10.1101/2023.03.15.23287287 — Posted: 2023-03-18
Trends in Pediatric Firearm-Related Encounters during the COVID-19 Pandemic by Age Group, Race/Ethnicity, and Schooling Mode in Tennessee
McKay, T., Gastineau, K., Wrenn, J. O., Han, J. H., Storrow, A. B.
10.1101/2023.03.17.23287413 — Posted: 2023-03-18
Protection against symptomatic SARS-CoV-2 BA.5 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original (ancestral) monovalent vaccines - a matched cohort study in France
Auvigne, V., Tamandjou, C., Schaeffer, J., Vaux, S., Parent du Chatelet, I.
10.1101/2023.03.17.23287411 — Posted: 2023-03-18
Demographic and co-morbidity characteristics of patients tested for SARS-CoV-2 from March 2020 to January 2022 in a national clinical research network: results from PCORnet(R)
Block, J. P., Marsolo, K. A., Nagavedu, K., Bailey, L. C., Boehmer, T. K., Fearrington, J., Harris, A. M., Garrett, N., Goodman, A. B., Gundlapalli, A. V., Kaushal, R., Kho, A., McTigue, K. M., Nair, V. P., Puro, J., Shenkman, E., Weiner, M. G., Williams, N., Carton, T. W.
10.1101/2023.03.17.23287396 — Posted: 2023-03-18
Chest CT findings and outcomes of COVID-19 in second wave: A cross-sectional study in a tertiary care centre in Northern India
Cheema, T., Saroha, A., Kumar, A., Panda, P. K., Saxena, S.
10.1101/2023.03.17.23287423 — Posted: 2023-03-18
Magnipore: Prediction of differential single nucleotide changes in the Oxford Nanopore Technologies sequencing signal of SARS-CoV-2 samples
Spangenberg, J., Honer zu Siederdissen, C., Zarkovic, M., Triebel, S., Rose, R., Martinez Christophersen, C. V., Paltzow, L., Hegab, M. M., Wansorra, A. N., Srivastava, A., Krumbholz, A., Marz, M.
10.1101/2023.03.17.533105 — Posted: 2023-03-17
Molecular Neuropathology and Cerebrospinal Fluid Diagnostic Biomarkers of SARS-Cov2 Infection in Central Nervous System: A Scoping Review Protocol
Kyaruzi, V. M., Mduma, E., Bandyopadhyay, S., Nyalundja, A. D., Kamabu, K., Atron, B., Nathan, M., Itodo Daniel, J. O., Elamin, Y. Z., Marwa, B. B., Msemo, R., Naeem, A., jean de Dieu, T. M., Kumar, T. S., Tazoah, N. B., Chiazo, U. F., David, S. O., Nsavyimana, Y. J., Bureta, C. A., Rutabasibwa, N., Mchome, L. L., Shimber, E. T., Tirsit, A., Mfinanga, S., Hassen, G. W., Abdellaziz, O., Mwakigonja, A.
10.1101/2023.03.17.23287405 — Posted: 2023-03-17
A general computational design strategy for stabilizing viral class I fusion proteins
Gonzalez, K. J., Huang, J., Criado, M. F., Banerjee, A., Tompkins, S. M., Mousa, J. J., Strauch, E. M.
10.1101/2023.03.16.532924 — Posted: 2023-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).